Commentary on “Biomarkers in Alzheimer's Disease Drug Development.” Can't Live Without ‘Em

Alzheimer's and Dementia - United States
doi 10.1016/j.jalz.2010.06.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Commentary on “Alzheimer's Disease Drug Development and the Problem of the Blood-Brain Barrier”

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2009English

Calcineurin Inhibitors: 40 Years Later, Can't Live Without ...

Journal of Immunology
AllergyImmunology
2013English

Drug Development for Alzheimer's Disease: Recent Progress

Experimental Neurobiology
Molecular NeuroscienceNeurologyCellular
2010English

Biomarkers for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2006English

Biomarkers of Alzheimer's Disease

Neurobiology of Disease
Neurology
2009English

A New Roadmap for Drug Development for Alzheimer's Disease

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2013English

Circulating miRNA Biomarkers for Alzheimer's Disease

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2013English

Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease

PLoS ONE
Multidisciplinary
2012English

Biomarkers in Oncology Drug Development

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy